Logo image of XS4.DE

ON SEMICONDUCTOR (XS4.DE) Stock Fundamental Analysis

Europe - FRA:XS4 - US6821891057 - Common Stock

42.75 EUR
+1.17 (+2.83%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

5

XS4 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 57 industry peers in the Semiconductors & Semiconductor Equipment industry. While XS4 has a great health rating, its profitability is only average at the moment. XS4 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

XS4 had positive earnings in the past year.
In the past year XS4 had a positive cash flow from operations.
In the past 5 years XS4 has always been profitable.
Each year in the past 5 years XS4 had a positive operating cash flow.
XS4.DE Yearly Net Income VS EBIT VS OCF VS FCFXS4.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

XS4's Return On Assets of 3.55% is on the low side compared to the rest of the industry. XS4 is outperformed by 63.16% of its industry peers.
With a Return On Equity value of 5.87%, XS4 perfoms like the industry average, outperforming 45.61% of the companies in the same industry.
XS4 has a Return On Invested Capital of 8.13%. This is comparable to the rest of the industry: XS4 outperforms 47.37% of its industry peers.
XS4 had an Average Return On Invested Capital over the past 3 years of 19.04%. This is above the industry average of 14.80%.
The last Return On Invested Capital (8.13%) for XS4 is well below the 3 year average (19.04%), which needs to be investigated, but indicates that XS4 had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.55%
ROE 5.87%
ROIC 8.13%
ROA(3y)14.52%
ROA(5y)11.35%
ROE(3y)25.56%
ROE(5y)21.06%
ROIC(3y)19.04%
ROIC(5y)15.34%
XS4.DE Yearly ROA, ROE, ROICXS4.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

XS4's Profit Margin of 7.28% is on the low side compared to the rest of the industry. XS4 is outperformed by 70.18% of its industry peers.
In the last couple of years the Profit Margin of XS4 has grown nicely.
The Operating Margin of XS4 (17.54%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of XS4 has grown nicely.
The Gross Margin of XS4 (37.89%) is worse than 73.68% of its industry peers.
XS4's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.54%
PM (TTM) 7.28%
GM 37.89%
OM growth 3Y9.94%
OM growth 5Y18.56%
PM growth 3Y14.02%
PM growth 5Y42.07%
GM growth 3Y4.08%
GM growth 5Y4.89%
XS4.DE Yearly Profit, Operating, Gross MarginsXS4.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), XS4 is creating some value.
XS4 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for XS4 has been increased compared to 5 years ago.
Compared to 1 year ago, XS4 has an improved debt to assets ratio.
XS4.DE Yearly Shares OutstandingXS4.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
XS4.DE Yearly Total Debt VS Total AssetsXS4.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

An Altman-Z score of 4.43 indicates that XS4 is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 4.43, XS4 perfoms like the industry average, outperforming 43.86% of the companies in the same industry.
XS4 has a debt to FCF ratio of 2.62. This is a good value and a sign of high solvency as XS4 would need 2.62 years to pay back of all of its debts.
XS4 has a Debt to FCF ratio (2.62) which is in line with its industry peers.
XS4 has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
XS4's Debt to Equity ratio of 0.42 is on the low side compared to the rest of the industry. XS4 is outperformed by 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 2.62
Altman-Z 4.43
ROIC/WACC0.73
WACC11.11%
XS4.DE Yearly LT Debt VS Equity VS FCFXS4.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

XS4 has a Current Ratio of 5.02. This indicates that XS4 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.02, XS4 belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
A Quick Ratio of 3.37 indicates that XS4 has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.37, XS4 belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.02
Quick Ratio 3.37
XS4.DE Yearly Current Assets VS Current LiabilitesXS4.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The earnings per share for XS4 have decreased strongly by -35.47% in the last year.
XS4 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.88% yearly.
Looking at the last year, XS4 shows a very negative growth in Revenue. The Revenue has decreased by -17.93% in the last year.
Measured over the past years, XS4 shows a small growth in Revenue. The Revenue has been growing by 5.12% on average per year.
EPS 1Y (TTM)-35.47%
EPS 3Y10.62%
EPS 5Y21.88%
EPS Q2Q%-44.79%
Revenue 1Y (TTM)-17.93%
Revenue growth 3Y1.67%
Revenue growth 5Y5.12%
Sales Q2Q%-15.36%

3.2 Future

Based on estimates for the next years, XS4 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.96% on average per year.
Based on estimates for the next years, XS4 will show a small growth in Revenue. The Revenue will grow by 4.23% on average per year.
EPS Next Y-40.63%
EPS Next 2Y-12.75%
EPS Next 3Y2.45%
EPS Next 5Y10.96%
Revenue Next Year-16.27%
Revenue Next 2Y-5.69%
Revenue Next 3Y-0.55%
Revenue Next 5Y4.23%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
XS4.DE Yearly Revenue VS EstimatesXS4.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
XS4.DE Yearly EPS VS EstimatesXS4.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.51, XS4 is valued correctly.
Based on the Price/Earnings ratio, XS4 is valued cheaper than 84.21% of the companies in the same industry.
XS4's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.76.
With a Price/Forward Earnings ratio of 16.48, XS4 is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XS4 indicates a somewhat cheap valuation: XS4 is cheaper than 77.19% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.21. XS4 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.51
Fwd PE 16.48
XS4.DE Price Earnings VS Forward Price EarningsXS4.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XS4 indicates a somewhat cheap valuation: XS4 is cheaper than 75.44% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of XS4 indicates a rather cheap valuation: XS4 is cheaper than 85.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.84
EV/EBITDA 11.64
XS4.DE Per share dataXS4.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

XS4 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.75
EPS Next 2Y-12.75%
EPS Next 3Y2.45%

0

5. Dividend

5.1 Amount

No dividends for XS4!.
Industry RankSector Rank
Dividend Yield N/A

ON SEMICONDUCTOR

FRA:XS4 (10/6/2025, 7:00:00 PM)

42.75

+1.17 (+2.83%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-04 2025-08-04/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners111.02%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap17.48B
Analysts71.82
Price Target49.95 (16.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.02%
Min EPS beat(2)-3.5%
Max EPS beat(2)5.53%
EPS beat(4)1
Avg EPS beat(4)-1.07%
Min EPS beat(4)-5.32%
Max EPS beat(4)5.53%
EPS beat(8)5
Avg EPS beat(8)-0.19%
EPS beat(12)9
Avg EPS beat(12)1.66%
EPS beat(16)13
Avg EPS beat(16)3.98%
Revenue beat(2)1
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)0.12%
Revenue beat(4)1
Avg Revenue beat(4)-2.23%
Min Revenue beat(4)-4.89%
Max Revenue beat(4)0.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.18%
Revenue beat(12)3
Avg Revenue beat(12)-1.62%
Revenue beat(16)5
Avg Revenue beat(16)-1.31%
PT rev (1m)-0.87%
PT rev (3m)10.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.93%
EPS NY rev (1m)0.04%
EPS NY rev (3m)1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.5%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.66%
Valuation
Industry RankSector Rank
PE 16.51
Fwd PE 16.48
P/S 3.19
P/FCF 15.84
P/OCF 11.14
P/B 2.57
P/tB 3.4
EV/EBITDA 11.64
EPS(TTM)2.59
EY6.06%
EPS(NY)2.59
Fwd EY6.07%
FCF(TTM)2.7
FCFY6.31%
OCF(TTM)3.84
OCFY8.97%
SpS13.4
BVpS16.63
TBVpS12.57
PEG (NY)N/A
PEG (5Y)0.75
Profitability
Industry RankSector Rank
ROA 3.55%
ROE 5.87%
ROCE 9.46%
ROIC 8.13%
ROICexc 10.67%
ROICexgc 13.59%
OM 17.54%
PM (TTM) 7.28%
GM 37.89%
FCFM 20.15%
ROA(3y)14.52%
ROA(5y)11.35%
ROE(3y)25.56%
ROE(5y)21.06%
ROIC(3y)19.04%
ROIC(5y)15.34%
ROICexc(3y)25.66%
ROICexc(5y)20.08%
ROICexgc(3y)33.75%
ROICexgc(5y)27.59%
ROCE(3y)22.16%
ROCE(5y)17.85%
ROICexcg growth 3Y-8.83%
ROICexcg growth 5Y5.63%
ROICexc growth 3Y-1.27%
ROICexc growth 5Y11.96%
OM growth 3Y9.94%
OM growth 5Y18.56%
PM growth 3Y14.02%
PM growth 5Y42.07%
GM growth 3Y4.08%
GM growth 5Y4.89%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 2.62
Debt/EBITDA 1.9
Cap/Depr 83.14%
Cap/Sales 8.48%
Interest Coverage 18.49
Cash Conversion 103.21%
Profit Quality 276.77%
Current Ratio 5.02
Quick Ratio 3.37
Altman-Z 4.43
F-Score5
WACC11.11%
ROIC/WACC0.73
Cap/Depr(3y)184.74%
Cap/Depr(5y)142.8%
Cap/Sales(3y)13.78%
Cap/Sales(5y)11.57%
Profit Quality(3y)59.82%
Profit Quality(5y)95.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-35.47%
EPS 3Y10.62%
EPS 5Y21.88%
EPS Q2Q%-44.79%
EPS Next Y-40.63%
EPS Next 2Y-12.75%
EPS Next 3Y2.45%
EPS Next 5Y10.96%
Revenue 1Y (TTM)-17.93%
Revenue growth 3Y1.67%
Revenue growth 5Y5.12%
Sales Q2Q%-15.36%
Revenue Next Year-16.27%
Revenue Next 2Y-5.69%
Revenue Next 3Y-0.55%
Revenue Next 5Y4.23%
EBIT growth 1Y-51.37%
EBIT growth 3Y11.77%
EBIT growth 5Y24.63%
EBIT Next Year-17.86%
EBIT Next 3Y6.9%
EBIT Next 5Y13.49%
FCF growth 1Y10.32%
FCF growth 3Y-2.05%
FCF growth 5Y82.37%
OCF growth 1Y-27.68%
OCF growth 3Y2.27%
OCF growth 5Y22.37%